Innovative Health Initiative (IHI) and precision medicine
Picture of the results of a poll taken during the IHI kick-off and brokerage event where the audience was asked what they thought the top priorities for IHI funding should be.
I attended the kick-off meeting of the Innovative Health Initiative (IHI) on Tuesday. One of the things they did in the plenary session is to poll the audience as to the priority areas for IHI call topics. As you can see from the resulting word cloud “precision medicine” came out as one of the top priorities. It is somewhat of a synchronicity as I was working on the webpage for the Precision Medicine BioPharmaX on Monday.
The common interest speaks to the fact that precision medicine is one of those concepts that have been around for quite some time, yet we have been unable to achieve their full realization in the life sciences and healthcare. Some of this delay may simply be that there has not been enough time for the science to mature.
However, life sciences and healthcare innovation is a complex endeavour that requires multiple disciplines and multiple stakeholders. Which is one of the reasons why we are creating Precision Medicine BioPharmaX.
-
BioPharmaX is a concept partnerships that span multiple initiatives and disease domains that can drive an exponential pace of innovation in the life sciences and healthcare. You can learn more about it here
